Taiwan FDA registration 8afb2d8656030481b8757c5acadf7083
CJ Rapitest AFP test kit
TW: 啟哲速測家甲型胎兒蛋白檢測試劑組
Taiwan·Risk Class 2·MD·Qizhe Biotechnology Co., Ltd·Registered Jan 19, 2018 – Jan 19, 2023ExpiredRegistration details
- Analysis ID
- 8afb2d8656030481b8757c5acadf7083
- License Form
- Ministry of Health Medical Device Manufacturing No. 005814
Company information
- Manufacturer
- Qizhe Biotechnology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Qizhe Biotechnology Co., Ltd
Product details
- Intended Use
- Qualitative detection of human serum α-Fetoprotein (AFP).
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C6010 Tumor-associated antigen immunoassay system
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jan 19, 2018
- Expiry Date
- Jan 19, 2023
About this record
Access comprehensive regulatory information for CJ Rapitest AFP test kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8afb2d8656030481b8757c5acadf7083 and manufactured by Qizhe Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices